Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

3,668 public trials 792 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer

NCT00113516

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Pfizer Investigational Site Los Angeles, California, United States
  • Pfizer Investigational Site Newark, Delaware, United States
  • Pfizer Investigational Site Newark, Delaware, United States
  • Pfizer Investigational Site Wilmington, Delaware, United States
View all 31 locations
View Trial Details
Completed

An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer

NCT00054899

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +12 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • Cancer Centers of Florida Orlando, Florida, United States
  • New York Oncology Hematology Albany, New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

Pulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC)

NCT00174772

Conditions
Lung Diseases, Lung Neoplasms, Neoplasms, +4 more
Locations
  • Sanofi-Aventis Administrative Office Diegem, Belgium
  • Sanofi-Aventis Administrative Office Helsinki, Finland
  • Sanofi-Aventis Administrative Office Paris, France
  • Sanofi-Aventis Administrative Office Milan, Italy
View Trial Details

Related conditions